U.S.-China safety deal goes official soon

Expect lots of smiles and hand-shaking next month, when China and the U.S. are expected to sign a new drug safety pact. Beijing announced today that it will cooperate with the U.S. to ensure the safety of pharmaceuticals, and it's planning a new sweep against false advertising, too. Details of the bilateral agreement weren't forthcoming.

Yesterday, the government trumpeted its ad-quashing strength, citing 33,000 false ads it had swept aside over the last six months. The safety agreement is expected to include a crackdown on exporters and closer scrutiny of drugs old in-country. Whether it will bear more fruit than previous pledges remains to be seen.

- read the report from the Guardian

Suggested Articles

Teva is reportedly going for a moonshot with a $15 billion drug offer to settle its opioid cases. It's a plan that might just work, one analyst said.

CSL has sued a former exec who its says stole thousands of key documents as he left for competitor Pharming.

Influential U.S. cost watchdog ICER gave its blessing to Johnson & Johnson and Amarin's CV drugs. But there's a big catch for both meds.